-+ 0.00%
-+ 0.00%
-+ 0.00%

Union Tool And 2 Japanese Growth Stocks To Watch

Simply Wall St·11/02/2026 02:30:56
语音播报

Asian share markets recently felt pressure as investors questioned how long the current AI boom can run, which has pulled attention away from quieter parts of the market. That shift creates an opening in fast growing Japanese companies with healthy finances that are not priced off the latest hype cycle. This article highlights three stocks from our high growth potential screener that analysts expect to deliver strong performance over the next few years.

The three stocks below are just a sample from this idea, and the full screen surfaced 15 more Japanese high growth candidates with similar stories of analyst growth expectations and solid balance sheets that do not rely on AI enthusiasm to attract attention. To see the complete high growth list, head straight into the Best high growth potential screener and use it to identify, compare, and analyze the highest conviction opportunities that fit your own criteria.

Union Tool (TSE:6278)

Union Tool makes high precision cutting tools and motion components, with its PCB drills, routers and ultra precision micro hole drills aligned to electronics and semiconductor manufacturing. Revenue is split roughly evenly between Asia at ¥31.1b and Japan at ¥31.0b, and the business carries a market value of about ¥239.3b.

Union Tool operates in a high growth theme, with analysts in the source material expecting revenue to rise around 23.4% a year and earnings about 27.5% a year over the next 3 years, supported by an 18.8% net margin and capacity expansion that only pays off if one pressure on future demand holds in place.

If that demand pressure interests you, go straight to the 3 key rewards and 1 important major warning sign to see how Union Tool’s upside and pressure points compare.

TSE:6278 Earnings & Revenue Growth as at Nov 2026
TSE:6278 Earnings & Revenue Growth as at Nov 2026

Rorze (TSE:6323)

Rorze develops automation systems for chip and flat panel display production, with its semiconductor and FPD related equipment segment generating about ¥141.7b of revenue versus ¥1.2b from life science. That puts the high throughput wafer handling line at the center of its ¥641.4b market cap story.

Rorze is included in this high growth screener because its wafer handling gear is tied directly to semiconductor capital spending. Raised guidance and expanding margins fit that profile, although everything depends on how one pressure on fab investment patterns plays out.

That hinge point on fab appetite is exactly why it is worth going straight to the 3 key rewards and 2 important warning signs (1 is major!) to see how Rorze’s risk and upside really balance.

TSE:6323 Earnings & Revenue Growth as at Nov 2026
TSE:6323 Earnings & Revenue Growth as at Nov 2026

Lasertec (TSE:6920)

Lasertec is a Yokohama based equipment maker that designs and sells inspection and measurement systems for chip production. Its EUV mask and wafer inspection tools are closely tied to the high growth potential theme. The business has a market value of about ¥3,381.9b.

Analysts expect Lasertec’s earnings to grow about 22.42% a year over the next 3 years, supported by EUV inspection tools that are central to next generation chip production and a balance sheet that is not flagged as stretched for that period. Investor attention now hinges on what happens if one assumption about EUV driven demand shifts.

If that EUV demand assumption is the swing factor for you, go straight to the 1 key reward and 1 important major warning sign to see where Lasertec’s growth story could bend.

TSE:6920 Earnings & Revenue Growth as at Nov 2026
TSE:6920 Earnings & Revenue Growth as at Nov 2026

Seeking Alternatives Before The Crowd

Fresh ideas do not stay quiet for long. Once momentum builds, prices can move fast and chances close. Scan for breakouts still flying under the radar for now and aim to participate early.

  • Spot check strong cash generators before they get fully caught by the crowd by running the 14 high quality undervalued stocks while pricing still reflects under the radar fundamentals.
  • Consider structural shifts in healthcare by reviewing the 10 healthcare AI stocks while these operators are still building momentum and data advantages that others have not yet priced.
  • Focus on operators with resilient characteristics and room to keep compounding by screening the 24 resilient stocks with low risk scores before defensive quality is widely recognized and yields start dropping.